Home page > Quality health systems and services | Health workforce

Health professionals


Please find all related articles below.



Health Ministers’ Conclusions address patient safety and antimicrobial resistance


In recent years, antimicrobial resistance (AMR) has been identified as a major health threat. The 2014 European Antibiotic Awareness Day drew attention to the consequences arising from the overuse and misuse of antibiotics, for instance through self-medication. The emergence of multi-drug resistant ’superbugs’ as a result is a serious threat to health throughout Europe. European Health Ministers recently issued Council conclusions which expand the EU level discourse about (...)
18/12/2014

Good practice in ethical international recruitment at Calaraşi County Emergency Hospital (Romania)


Since EU accession in 2007 Romania and Bulgaria have struggled to retain qualified health professionals. Doctors and nurses in particular have been leaving in significant numbers. Given the impacts of out-migration on health system sustainability and access to healthcare, the initiative taken by a regional hospital in Southern Romania has been highlighted by the Health Workers For All project as good practice in effective cross-border cooperation. Long-term planning and the use of (...)
18/12/2014

[Joint press release] Is President-elect Juncker erecting a smoke screen around patient safety?


28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament. Last week’s statement of the European Commission’s President-elect that the competence for (...)
28/10/2014

[Open letter to President-elect Juncker] Are we to understand that the portfolios for medical devices and health technologies will not remain with the Health Commissioner?


Further to our Joint Letter of 16 September 2014 (1) , we are contacting you again to express our gratitude for your decision (2) to move the competence for medicines and pharmaceutical products back into the hands of the European Commissioner for Health. We firmly believe that this directorate is best placed to ensure a good balance between economic and public health objectives while promoting ‘smart, sustainable and inclusive’ growth for Europe. 28 October 2014, Brussels (...)
28/10/2014

[Open letter] To Heads of State and Government of the European Union Member States on Pharmaceutical Policy in the Public Interest


Brussels, 2 October 2014 - We are writing to support Member States who have already expressed their concerns on the decision of European Commission President Elect Jean-Claude Juncker to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of Internal Market and Industry within the new Commission. We would like to ask for your full support to have that decision reversed. Dear Head of States, Dear Prime (...)
02/10/2014

5th ESWI Influenza Conference highlights benefits of vaccination


The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and ’science/policy interface’ sessions examined the issue of low vaccination uptake in many Member States, as well as other issues related to pandemic preparedness and communication aspects of influenza-related health threats. In the opening plenary, ’Why should influenza be a public (...)
26/09/2014

mHealth - an essential component towards integrated care


More integrated prevention and care models have long been recognised as important elements in moving towards better quality and sustainability in healthcare, in particular in view of the rising burden of non-communicable diseases and demographic change, and the complexities of multiple morbidities that this brings. By Sascha Marschang, EPHA Policy Manager for Health Systems and Milena Richter, Senior Director European Public Affairs, Sanofi. While healthcare systems move towards (...)
01/09/2014

[EPHA response] mHealth Green Paper consultation


22 July 2014 - Following in-depth discussions with members, EPHA responded to the European Commission’s public consultation on its Green Paper on mobile health (mHealth) in early July. In its response, EPHA emphasises that mHealth development should not only be seen as a way to gain cost efficiencies, but that relevant solutions - including smartphone applications - must first and foremost aim to bring concrete benefits for different types of end users including patients and health (...)
25/07/2014

Strong Health Workforces and Sustainable Health Systems - HW4All


As a fundamental pillar of the social and welfare model that defines and strengthens European identity, a solid health workforce is a public resource that must be secured at the local, national and global levels. Therefore EPHA supports the HW4All initiative with its goal of reinforcing the ethical guidelines outlined in the 2010 WHO Global Code of Practice on the International Recruitment of Health Personnel. Recent developments On 15 and 16 July, EPHA attended separate meetings with (...)
23/07/2014

Launch of European Call to Action ’A Health Worker for Everyone, Everywhere!’


On 5 June 2014, the partners of the ’Health workers for all and all for health workers’ (HW4All) project released a European Call to Action in support of the implementation of the WHO Global Code of Practice on the International Recruitment of Health Personnel. EPHA has been involved in raising awareness of this Code since 2011 and will be co-promoting the European Call to Action, entitled ’A health worker for everyone, everywhere!’, which is now open for signatures (...)
06/06/2014